Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling
Vessel Plus · 2017
DOI: 10.20517/2574-1209.2016.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vessel Plus, 2017. Verfasst von Yunzhou Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Program, Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular Biology Program, Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma, OK 73104, USA.
Förderung
- NHLBI NIH HHS
- NCRR NIH HHS
Zitieren
APA
Dong, Y., Wu, H., Dong, J., Song, K., Rahman, H. A., Towner, R., & Chen, H. (2017). Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling. Vessel Plus. https://doi.org/10.20517/2574-1209.2016.01
Vancouver
Dong Y, Wu H, Dong J, Song K, Rahman HA, Towner R, et al. Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling. Vessel Plus. 2017. doi:10.20517/2574-1209.2016.01
BibTeX
@article{Dong2017,
author = {Dong, Yunzhou and Wu, Hao and Dong, Jerry and Song, Kai and Rahman, Habibunnabi Ashiqur and Towner, Rheal and Chen, Hong},
title = {Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling},
journal = {Vessel Plus},
year = {2017},
doi = {10.20517/2574-1209.2016.01}
}
EUVIMED